Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 28, 2024, titled "Caplin Steriles Limited, our Subsidiary, gets USFDA approval for Ketorolac tromethamine Ophthalmic Solution 0.5%".
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 28, 2024, titled "Caplin Steriles Limited, our Subsidiary, gets USFDA approval for Ketorolac tromethamine Ophthalmic Solution 0.5%".